Controversies of radiotherapy in human epidermal growth factor receptor (HER)-2 positive breast cancer patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Controversies of radiotherapy in human epidermal growth factor receptor (HER)-2 positive breast cancer patients

Published:2021-03-12 Issue:1 Volume:165 Page:19-25
ISSN:1213-8118
Container-title:Biomedical Papers
language:
Short-container-title:BIOMED PAP

Author:

Kolarova Iveta,Melichar Bohuslav,Vanasek Jaroslav,Ryska Ales,Horackova Katerina,Petera Jiri,Vosmik Milan,Sirak Igor,Dolezel Martin

Publisher

Palacky University Olomouc

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://biomed.papers.upol.cz/doi/10.5507/bp.2021.007.pdf

Reference47 articles.

1. Breast Cancer Subtypes and the Risk of Local and Regional Relapse

2. Giuliano AE, Connolly JL, Edge SB, Mittendorf EA, Rugo HS, Solin LJ, Weaver DL, Winchester DJ,Hortobagyi GN. Breast cancer-major changes in the American Joint Committee on Cancer eighth edition cancer staging manual;CA Cancer J Clin,2017

3. Staging for Breast Cancer Patients Receiving Neoadjuvant Chemotherapy: Utility of Incorporating Biologic Factors

4. Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor–Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20

5. Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3